Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564860 · ClinicalTrials.gov registry record
HBP Device EGM Data Collection
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 200
- Enrollment target
NCT03564860 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 200 participants.
The verdict
NCT03564860 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a single-arm, non-randomized, non-blinded study designed to collect device data in patients with permanent His bundle (HB) pacing lead and an existing Abbott permanent pacemaker, defibrillator, or cardiac resynchronization device. Prospective data collection includes surface electrocardiograms, intracardiac electrograms, and pacing parameters, recorded during a patient visit. Additional retrospective data collection includes procedural data during the HB pacing lead and device implant. Up to 200 subjects will participate in this clinical investigation. The clinical investigation will be conducted at up to 8 centers worldwide. The total duration of the clinical investigation is expected to be 1 year, including enrollment and data collection from all subjects.
Interventions
- PROCEDURE Device data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-07-17 |
| Est. Completion | 2020-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564860
The ClinicalTrials.gov registry entry for NCT03564860 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Device data collection is the first listed.
NCT03564860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03564860 about?
NCT03564860 is a clinical study titled "HBP Device EGM Data Collection". This is a single-arm, non-randomized, non-blinded study designed to collect device data in patients with permanent His bundle (HB) pacing lead and an existing Abbott permanent pacemaker, defibrillator, or cardiac resynchronization device. Prospective data collection includes surface electrocardiogra...
What is the current status of trial NCT03564860?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2018-07-17. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT03564860?
The interventions under investigation include: Device data collection (PROCEDURE).
Who is sponsoring clinical trial NCT03564860?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.